Disruption of O-linked N-Acetylglucosamine Signaling Induces ER Stress and β Cell Failure  by Alejandro, Emilyn U. et al.
ArticleDisruption of O-linked N-Acetylglucosamine
Signaling Induces ER Stress and b Cell FailureGraphical AbstractHighlightsd Mice lacking b cell OGT develop diabetes and b cell failure
d OGT-deficient b cells have increased ER-stress-induced
apoptosis
d OGT-deficient b cells have decreased Akt-driven proliferation
d OGT-deficient b cells have reduced calcium signaling and
insulin contentAlejandro et al., 2015, Cell Reports 13, 2527–2538
December 22, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.11.020Authors
Emilyn U. Alejandro, Nadejda Bozadjieva,
Doga Kumusoglu, ..., Leslie S. Satin,
Peter Arvan, Ernesto Bernal-Mizrachi
Correspondence
ebernalm@med.miami.edu
In Brief
Aberrant O-GlcNAcylation has been
linked to diabetes. However, little is
known about the role of O-GlcNAcylation
in insulin-producing b cell function and
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diabetes and b cell failure because of
increased ER-stress-induced apoptosis
and decreased Akt-induced proliferation.
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Nutrient levels dictate the activity of O-linked N-ace-
tylglucosamine transferase (OGT) to regulate
O-GlcNAcylation, a post-translational modification
mechanism to ‘‘fine-tune’’ intracellular signaling
and metabolic status. However, the requirement of
O-GlcNAcylation for maintaining glucose homeosta-
sis by regulating pancreatic b cell mass and func-
tion is unclear. Here, we reveal that mice lacking b
cell OGT (bOGT-KO) develop diabetes and b cell
failure. bOGT-KO mice demonstrated increased
ER stress and distended ER architecture, and these
changes ultimately caused the loss of b cell mass
due to ER-stress-induced apoptosis and decreased
proliferation. Akt1/2 signaling was also dampened
in bOGT-KO islets. The mechanistic role of these
processes was demonstrated by rescuing the
phenotype of bOGT-KO mice with concomitant
Chop gene deletion or genetic reconstitution of
Akt2. These findings identify OGT as a regulator of
b cell mass and function and provide a direct link
between O-GlcNAcylation and b cell survival by
regulation of ER stress responses and modulation
of Akt1/2 signaling.INTRODUCTION
Type 2 diabetes (T2D) occurs when pancreatic b cells fail to
adequately expand and function sufficiently when there is
increased insulin demand with insulin resistance (Alejandro
et al., 2015). The ability of b cells to fulfill the demand in insulin
is dependent on both b cell mass and function. Although the
pathogenesis of b cell dysfunction in T2D remains controversial,
failure of b cell mass and function has been attributed to multipleCell Repfactors including endoplasmic reticulum (ER) stress (Eizirik et al.,
2008; Ferrannini, 2010). Deficits in adaptive b cell mass are partly
attributed to enhanced apoptosis in T2D (Marchetti et al., 2010)
and inherent poor self-renewal capabilities of b cells (Dor et al.,
2004; Teta et al., 2007).
During the pathogenesis of T2D, b cells are continually
exposed to high levels of glucose. Approximately 3%–5% of
glucose entering the b cell is shunted to the hexosamine
biosynthetic pathway (HBP) for the synthesis of uridine diphos-
phate-N-acetylglucosamine (UDP-GlcNAc), the substrate for
O-GlcNAcylation, a dynamic and reversible post-translational
protein modification analogous to phosphorylation that affects
the function, stability, and sub-cellular localization of b cell pro-
teins (i.e., Pdx-1). O-GlcNAcylation involves the addition of a sin-
gle O-GlcNAc to serine or threonine residues on nuclear and
cytosolic proteins solely by the enzyme O-linked GlcNAc
transferase (OGT). The O-GlcNAc is removed by the O-linked
b-N-acetyl hexosaminidase (O-GlcNAcase or OGA) enzyme.
O-GlcNAcylation has been implicated in the etiology of insulin
resistance and glucose toxicity in diabetes (Yang et al., 2008;
Copeland et al., 2008). Variants in OGA are associated with
T2D (Lehman et al., 2005), suggesting the importance of
O-GlcNAcylation in human diabetes. However, it is poorly under-
stood howO-GlcNAcylationmodulates b cell responses to affect
diabetes.
OGT is encoded by a single gene on the X chromosome and
is critical for development because whole-body deletion of
OGT is embryonically lethal (Shafi et al., 2000). Although
b cells uniquely express high levels of OGT, the importance
of O-GlcNAcylation in insulin-secreting cells is unclear.
O-GlcNAcylation of critical insulin signaling proteins to regulate
metabolism (IRS-1, PDK1, Akt1/2, and FoxO1) and transcription
factors required for insulin biosynthesis (NeuroD1, Pdx-1, and
MafA) have been demonstrated, implying the importance of
O-GlcNAcylation by OGT in b cells (Andrali et al., 2007; Gao
et al., 2003). Filholaud et al. demonstrated that O-GlcNAcylation
is also essential for b cell development in vitro (Filhoulaud et al.,
2009). The effect of decreased O-GlcNAcylation on b cellorts 13, 2527–2538, December 22, 2015 ª2015 The Authors 2527
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Figure 1. Conditional Deletion of OGT in b
Cells Causes Severe Hyperglycemia and
Glucose Intolerance in an Age-Dependent
Manner
(A and B) OGT protein level in primary mouse islet
and acinar (A), and quantification is shown in (B).
(C) OGT protein level and quantification in islets
from 8-week-old bOGT/ mice.
(D) O-GlcNAc level, a readout of OGT activity, in
islets from 8-week-old bOGT/ and control mice.
(E and F) Development of hyperglycemia in female
(E) or male (F) bOGT-KO mice compared to
control.
(G–J) Intraperitoneal glucose tolerance test
(IPGTT) was performed in female (G and I) and
male (H and J) bOGT-KO mice and littermate
control. *p < 0.05 versus bOGT-KO and control.function has been tested by overexpressing OGA in b cells: these
transgenic mice have increased glucose intolerance, decreased
insulin synthesis, and secretory capacity only at young age (Soe-
santo et al., 2011). However, the mechanisms driving these phe-
notypes remain unknown.
The present studies investigate the direct requirement of
O-GlcNAcylation in regulating b cell mass and function in vivo.
Using multiple genetic approaches, we report that female and
male mice harboring b cell OGT deletion (bOGT/ or bOGT/y,
respectively) developed severe hyperglycemia, glucose intoler-
ance, and impaired insulin secretion, and these mice ultimately
exhibit severe diabetes due to b cell failure. Loss of b cell mass
due to enhanced apoptosis was preceded by ER stress and
downregulation of critical prosurvival proteins Akt1/2 and
Pdx-1. Deletion of one Chop allele, a protein induced by ER
stress, improves hyperglycemia and restores b cell mass in
bOGT/y confirming the critical mechanistic role of ER stress
in the loss of b cells. Finally, the rescue of the metabolic
dysfunction in bOGT/y mice overexpressing of Akt2
[bOGT/;caAkt(Tg)] highlights the importance of Akt signaling2528 Cell Reports 13, 2527–2538, December 22, 2015 ª2015 The Authorsin islets lacking OGT. Together, these
data implicate that loss of OGT leads to
deterioration of b cell mass, defects in in-
sulin secretion, and diabetes. These data
identify OGT as a regulator of b cell mass
and function and emphasize the
emerging role of this protein in b cell sur-
vival by modulating ER stress and Akt
signaling.
RESULTS
Conditional Deletion of OGT in b
Cells Causes Severe
Hyperglycemia in an Age-
Dependent Manner
Assessment of OGT expression in acinar
and islet lysates demonstrated that this
protein is expressed primarily in islets
(Figures 1A and 1B). To identify the impor-tance of OGT in b cell mass and function, we generatedmicewith
conditional deletion of OGT in b cells (male RIPCre;OGTflox/y
(bOGT/y) or female RIPCre;OGTflox/flox (bOGT/) by crossing
male mice expressing Cre recombinase in b cells (RIPCre) (Her-
rera, 2000) with female OGTflox/flox (breeding scheme shown in
Figure S1A). Efficient and specific recombination of the RIPCre
enzyme in b cells of bOGT/y;CAGGFP (with GFP reporter) mice
was observed by EGFP expression in the majority of the b cells
(Figure S1B). OGT protein and mRNA levels were significantly
reduced in islets from bOGT/ mice compared to control
(OGTx/x; Figure 1C; Figure S1C). A reduction in OGA mRNA level
was also observed (data not shown). No alteration of OGT pro-
tein level was observed in hypothalamus and liver tissues (Fig-
ures S1D and S1E). A reduction of O-GlcNAcylation of proteins
in islets from bOGT/ mice confirmed OGT deletion in b cells
(Figure 1D). Body weight in male bOGT/y and female bOGT/
mice was comparable to littermate control (OGTx/y or OGTx/x
data not shown). Examination of female bOGT/ and littermate
control mice (OGT+/+, here in referred to as control) showed
hyperglycemia by 16 weeks of age (Figure 1E). In contrast,
bOGT/y mice developed hyperglycemia earlier than female
bOGT/ with glucose levels greater than 350 mg/dl by
10 weeks (Figure 1F). A reduction in fed insulin levels was
observed in 10-week-old bOGT/ mice (data not shown).
These studies demonstrate that male and female mice lacking
OGT in b cells develop severe hyperglycemia in an age-depen-
dent manner.
Young and Adult Mice with Conditional Deletion of OGT
in b Cells Develop Glucose Intolerance
Next, we assessed glucose homeostasis in young and adultmice
lacking OGT in b cells. We observed significant impairment in
glucose tolerance in female bOGT/ mice starting at 10 weeks,
a time point where they were still normoglycemic (Figures 1E and
1G). These mice developed severe glucose intolerance with
elevated fasting bloodglucose level by 20weeksof life (Figure 1I).
Because the male bOGT/y mice developed hyperglycemia at
earlier age, we tested glucose tolerance in 4-week-old males.
These mice demonstrated normal glucose tolerance compared
to control (Figure S1F). In contrast, 8-week-old bOGT/y male
mice exhibited glucose intolerance without fasting hyperglyce-
mia compared to control (Figure 1H). Impaired glucose tolerance
was even more significant with elevated fasting glucose level by
12 weeks of age (Figure 1J). Together, these data show young
male and female mice lacking OGT present glucose intolerance
without apparent alteration in random glucose level.
YoungMice Lacking OGT in bCells Exhibit Normal bCell
Mass while Adult Mice Show Reduced b Cell Mass
Next, we sought to assess the relative contribution of insulin
sensitivity in peripheral tissues. Despite demonstrating glucose
intolerance, 8-week-old male bOGT/y mice presented normal
insulin tolerance (Figure 2A), pointing to a defect in b cell mass
or insulin secretion. To tease apart the relative contribution of b
cell mass and function, we first assessed b cell mass in various
ages. Because we observed similar phenotype in both genders,
we focused onmale bOGT/y. We observed no alteration in b cell
mass at 4- and 7-week-old bOGT/y mice compared to control
(Figures 2B and 2C). Examination of adult 12-week-old bOGT/y
mice exhibited significant reduction in b cell mass (Figure 2D).
Adult female bOGT/ mice also demonstrated reduced b cell
mass (Figure S2A). The reduction in b cell mass at 3 months
was associated with a significant decrease in proliferation (Fig-
ure 2E), as well as induction of b cell death measured by TUNEL
staining (Figure 2F). Not surprisingly, significant reduction in
b cell mass was associated with blunted insulin secretion in
12-week-old bOGT/y mice compared to control (Figure 2G).
Thus, significant reduction in b cell mass was only observed in
adult mice harboring OGT deletion in b cells.
Young Mice Lacking OGT in b Cells Have a Defect in
Insulin Secretion, in Part Due to Altered Ca2+ Signaling
To identify an independent b cell function defect, islets from
8-week-old normoglycemic bOGT/ mice with normal b cell
mass were assessed for insulin secretion in vitro. We observed
diminished insulin secretion in response to both high glucose
and KCl (Figure 2H) in bOGT/ islets. Because we detected
reduced insulin secretion in response to KCl, we assessedCell RepCa2+ signaling and discovered that it was impaired in islets
from 8-week-old normoglycemic bOGT/ mice (Figure 2I).
Interestingly, approximately 33%of bOGT/ islets did not oscil-
late in response to 8 mM glucose compared to control (where
100% of islets oscillated). The oscillations of bOGT/ islets
showed reduced amplitude, period, and plateau fraction in
response to 11 mM glucose compared to control (Figures 2J–
2M). Assessment of time-dependent changes in calcium
signaling showed impaired Ca2+ signaling at different ages
including normoglycemic 6-week-old mice and hyperglycemic
19-week-old mice lacking OGT (Figure S2B). In addition to
altered Ca2+ signaling, we identified that insulin content was
reduced in normoglycemic bOGT/y and bOGT/mice (Figures
S3A and S3B). A reduction in insulin content can be partly ex-
plained by the downregulation of ins1, ins2, Pdx-1, andNueroD1
mRNA levels in islets from male and female mice lacking OGT
(Figures S3C–S3I). These data implicate reduced Ca2+ signaling
and insulin content as contributing factors to defective insulin
secretion in mice with conditional deletion of OGT.
Mice with Inducible Deletion of OGT in Mature b Cells
Develop Glucose Intolerance and Defective Insulin
Secretion
To assess the requirement of OGT in mature b cells, we deleted
OGT in b cells of 12-week-old mice. By breeding the inducible
MIPCre-ERTM and OGTflox/flox, we generated inducible
MIPCre-ERTM;OGT/y mice (ibOGT/y). The MIPCre-ERTM
recombination was efficient after tamoxifen (TMX) injection as
demonstrated by b cell-specific expression of GFP reporter
transgene (Rosa-CAGZsGreen) only in ibOGT/y islets (Fig-
ure S3J). Four weeks after TMX injection, we observed 70%
b cells expressing the GFP reporter both in ibOGT/y mice and
control mice (MIPCre-ERTM; CAG-ZsGreen, Figure S3K).
ibOGT/y mice did not develop hyperglycemia compared to
bOGT/y mice (data not shown). Eight weeks post-TMX injection
resulted in moderate but significant glucose intolerance in
ibOGT/y mice that worsened with age (Figures 3A and 3B). Sig-
nificant glucose intolerance was observed at 12 and 22 weeks
post-OGT ablation. In parallel to the glucose intolerance, an in-
sulin secretion defect was detected in ibOGT/y mice by
glucose-stimulated insulin secretion (GSIS) test in vivo, confirm-
ing the importance of OGT in insulin secretion (Figure 3C).
No significant changes in b cell mass were observed between
ibOGT/y and control mice at 22 weeks post-TMX injection (Fig-
ure 3D). These data from the induciblemodel clearly suggest that
OGT inmature b cells is important for regulating insulin secretion.
Phloridzin Partially Ameliorates the Development of
Diabetes in Mice Lacking OGT in b Cells
Because a rapid loss in b cell mass from 4 to 12 weeks old in
bOGT/y and not in ibOGT/y mice was observed, we hypothe-
sized that glucotoxic conditions could play a role on the decline
of b cells. To assess an independent effect of glucotoxicity
contributing to b cell mass loss, we treated bOGT/y mice with
Phloridzin (PHZ), a naturally occurring metabolite that promotes
glucose excretion in the kidney via inhibition of sodium-glucose
contransporters (Ehrenkranz et al., 2005). We established two
cohorts of mice implanted with osmotic pumps containingorts 13, 2527–2538, December 22, 2015 ª2015 The Authors 2529
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Figure 2. Young Mice Lacking OGT in b Cells Exhibit Normal b Cell Mass and Insulin Secretion Defect, While Adult Mice Show Reduced
b Cell Mass
(A) Intraperitoneal insulin tolerance test (ITT) was performed in 10-week-old bOGT/y mice and littermate control.
(B–D) b cell mass at 4- (B), 7- (C), and 12-week-old (D) bOGT/y.
(E and F) Proliferation assessed by KI67 staining (E), and apoptosis measured by TUNEL staining (F) in 12-week-old bOGT/y mice.
(G) In vivo glucose-stimulated insulin secretion (GSIS) in 12-week-old bOGT/y and control mice.
(H) Insulin secretion corrected to DNA content in response to 2 mM, 22 mM glucose, and 30 mM KCl of islets isolated from normoglycemic 8-week-old bOGT/
mice and control.
(I–M) Measurement of intracellular Ca2+ in islets of 8-week-old bOGT/mice. *p < 0.05 versus bOGT-KO and control; n values and age of mice are noted within
figures.
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Figure 3. Micewith Inducible Deletion ofOGT
in Mature b Cells Develop Glucose Intoler-
ance and Insulin Secretion Dysfunction
(A and B) Ablation of OGT in mature b cells caused
glucose intolerance and insulin secretion dysfunc-
tion. IPGTT was performed in male ibOGT/y
(MIPCre;OGT/y) post-tamoxifen treatment at 12 (A)
and 22 weeks (B).
(C) In vivo GSIS in ibOGT/y and control at 22 weeks
post-tamoxifen treatment.
(D) b cell mass assessment between ibOGT/y and
control mice measured at 22 weeks post-tamoxifen
treatment. *p < 0.05 versus ibOGT/y and control,
n = 4–6.PHZ. The first cohort was 10-week-old bOGT/y and control
mice. Prior to implantation, we observed glucose intolerance
and elevated fasting blood glucose level in bOGT/y mice
compared to control mice (Figure S4A). No effect on bodyweight
was observed in all mice treated with PHZ (data not shown). We
tested the efficiency of PHZ to lower glucose during a fasting
state on day 18 of treatment. After a 12-hr fasting, glucose levels
of bOGT/y mice were normalized to control (Figure S4B),
suggesting PHZ was effective in reducing blood glucose levels.
Fed glucose levels in bOGT/y mice were reduced and remained
comparable to control mice from day 2 to day 15 of PHZ
treatment (Figure S4C). However, the effect of PHZ was tran-
sient; bOGT/y mice eventually redeveloped hyperglycemia
and glucose intolerant on day 20 of PHZ treatment (Figures
S4C and S4D). When compared to age-matched bOGT/y
mice without PHZ treatment (Figure 1I; Figure S6D), PHZ treat-
ment improved basal fasting glucose levels at time 0 and partially
improved glucose tolerance in bOGT/y mice (Figures S4E and
S4F). Both fed and fasting insulin levels remained significantly
reduced in bOGT/y mice compared to control treated with
PHZ (Figures S4G and S4H). These data suggest that hypergly-
cemia contributed to the metabolic dysfunction in bOGT/y
mice. Because PHZ normalized fasting blood glucose levels in
bOGT/y mice treated with PHZ and glucose intolerance was still
present at this time, these data point to an inherent insulin secre-
tion defect in mice lacking OGT.
We established a younger cohort of mice to assess whether an
earlier and longer period of intervention could rescue the meta-
bolic dysfunction in bOGT/y mice. Seven-week-old bOGT/y
mice and control were implanted with ALZET pumps with PHZ.
Fed glucose levels of bOGT/y mice treated with PHZ were com-
parable to control up to 16 days of continuous treatment (Fig-
ure 4A). When comparing to age-matched mice without PHZ
treatment, bOGT/y mice treated with PHZ demonstrated
improved fed glucose levels (Figure 4B). On day 17 of PHZ treat-
ment, bOGT/y mice showed improved glucose tolerance thatCell Reports 13, 2527–2538, Dwas not different than that of the control
(Figure 4C). Comparing bOGT/y mice
with or without PHZ, the mice treated with
PHZ were metabolically better (Figures 4D
and 4E). However, PHZ treatment was
insufficient to maintain glucose tolerance
in bOGT/y mice on day 25 of treatment
(Figure 4F). Although bOGT/y mice treated with PHZ eventually
developed glucose intolerance compared to control with PHZ,
they remained metabolically better compared to bOGT/y mice
not treated with PHZ (Figure 4E). No differences in body weight
or fed or fasting insulin levels were observed (Figures 4G and
4H). Despite the transient improvement in glucose tolerance, no
restoration of b cell mass was observed in b cell mass in
bOGT/y mice treated with PHZ (Figure 4I). Interestingly, PHZ
treatment restored b cell proliferation and apoptosis in bOGT/y
mice to control levels (Figures 4J and 4K). Together these data
suggest that PHZ intervention was beneficial in the younger
cohort of bOGT/y mice and delayed the onset of diabetes. How-
ever, despite improving glucose levels and normalizing prolifera-
tion and apoptosis to control levels, PHZ did not restore b cell
mass in bOGT/ymice. Thus, itmay require an earlier intervention
or longer PHZ treatment to observe a major impact on b cell
mass. It is also possible that PHZ treatment only reduces the
stress on b cells, improving both proliferation and survival, but
not sufficient to rescue and/or restore b cell mass.
Downregulation of Prosurvival Akt1/2 and Pdx-1
Signaling and Enhanced ER Stress in Young and
Normoglycemic Mice Lacking OGT in b Cells
To unravel the cause of b cell dysfunction in mice with lacking
OGT in b cells, we focused our mechanistic studies on young
and normoglycemic animals. The PI3K/Akt/Pdx-1 signaling is
one of the major pathways regulating b cell survival, both
apoptosis and ER stress (Sachdeva et al., 2009). Because
Akt phosphorylation has been shown to be regulated by
OGT, we assessed the phosphorylation status of prosurvival
protein Akt1/2 at Ser473 in islets from normoglycemic bOGT/
mice. We found a reduction in phosphorylated Akt1/2 Ser473
with increased total Akt1/2 protein level (Figures 5A–5B0).
Pdx-1, a critical transcription factor for insulin gene transcrip-
tion and b cell survival, was reduced in 7-week-old female
bOGT/ islets compared to control (Figure 5C), suggestingecember 22, 2015 ª2015 The Authors 2531
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Figure 4. Phloridzin Partially Ameliorates
the Development of Diabetes in Mice Lack-
ing OGT in b Cells
(A) Random glucose levels in bOGT/y and control
mice treated with Phloridzin (PHZ).
(B) Comparison of random glucose levels in
bOGT/y mice treated with or without PHZ.
(C and D) IPGTT was performed on day 17 of PHZ
(C) or without treatment (D).
(E) Quantification of area under curve (AUC) of (D).
(F) IPGTT was performed on day 25 of PHZ.
(G and H) Random (G) and fasting (H) insulin levels
taken on day 20 of PHZ treatment.
(I–K) b cell mass (I), proliferation (J, measured by
KI67), and apoptosis (K, assessed by TUNEL
staining) between bOGT/y and control mice
on day 27 of PHZ treatment. *p < 0.05 versus
bOGT/y and control, n = 5.that Pdx-1 protein levels were altered before the loss in b cell
mass.
Despite normal glucose tolerance and b cell mass, 4-week-
old bOGT/y mice presented reduced insulin and elevated
proinsulin circulating levels (Figures S5A–S5C), suggesting
alterations in ER function. Co-staining with ER marker Calnexin
showed increased accumulation of proinsulin in the ER (Figures
S5D and S5E), supporting the notion that bOGT/y mice have
enhanced ER stress prior to development of glucose intolerance
and b cell failure. Elevated protein expression of ER stress
markers BiP, Chop, and phosphorylated EIF2a (Figures 5E–
5G) were observed in islets from 4-week-old bOGT/y mice.
Increased caspase12, a specific mediator of ER-stress-induced2532 Cell Reports 13, 2527–2538, December 22, 2015 ª2015 The Authorsapoptosis (Yoneda et al., 2001) was
evident in islets of bOGT/y mice (Fig-
ure 5H). Increased BiP levels were also
observed in female bOGT/ islets (Fig-
ure S5F). Furthermore, ER morphology
by electron microscopy showed dis-
tended ER in islets from 4-week-old
bOGT/y mice and abnormalities in
mitochondria morphology compared to
control (Figure 5I). Together, these data
suggest that ER stress is directly
involved in the early deterioration of
b cells before the onset of glucose
intolerance and hyperglycemia in mice
lacking OGT.
Akt Overexpression Prevents
Hyperglycemia and Improves
Glucose Tolerance by Normalizing
b Cell Mass in Mice Lacking OGT in
b Cells
Prosurvival Akt signaling was reduced
in islets of 8-week-old bOGT/ mice;
thus, we hypothesized that Akt over-
expression in b cells ameliorates the
metabolic phenotype of mice lackingOGT. To directly assess the involvement of Akt, we gener-
ated transgenic mice overexpressing Akt [CaAkt(Tg)] (Ber-
nal-Mizrachi et al., 2001) with b cell-specific deletion
of OGT [bOGT/;CaAkt(Tg)]. The onset of hyperglycemia
was prevented in bOGT/ mice overexpressing Akt
[bOGT/;CaAkt(Tg)] compared to bOGT/ mice (Figure 6A).
We observed increased fed and fasting insulin levels in the
bOGT/;CaAkt(Tg) compared to bOGT/ mice alone. As ex-
pected, Akt overexpressing mice showed elevated fed and
fasting insulin compared to wild-type control (Figures 6B
and 6C). As shown in previous cohorts, glucose intolerance
was observed in 9-week-old bOGT/ mice that worsened
with age (Figure 6D). Mice lacking OGT in b cells exhibited
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Figure 5. Downregulation of Prosurvival Akt1/2 and Pdx-1 Signaling and Enhanced ER Stress in Young and Normoglycemic Mice Lacking
OGT in b Cells
(A) Downregulation of prosurvival Akt1/2 at Ser473 and Pdx-1 in islets of normoglycemic 8-week-old female bOGT/ mice.
(B–C) Quantification phosphorylated Akt1/2(Ser473)/Total Akt one-half (B), total Akt/tubulin (B0), and Pdx-1/tubulin (C).
(D–G) ER stressmarkers protein expression in islets from normoglycemic 4-week-old bOGT/y mice; BiP (D), Chop (E), phosphorylated eIF2a (F), and Caspase-12
(G) in islets of 4-week-old bOGT/y mice.
(H) Electron microscopy images of b cell showing distended ER (arrow) and rounded mitochondria from 4-week-old bOGT/y mice. *p < 0.05 versus bOGT-KO
and control, n = 3.worse glucose intolerance at 22 weeks old compared to
bOGT/;CaAkt(Tg), suggesting that overexpression of Akt
improved glucose tolerance in mice lacking OGT (Figure 6E).
GSIS assessment in vivo suggested that bOGT/;CaAkt(Tg)
had increased basal and stimulated insulin values compared
to bOGT/ mice (Figure 6F). b cell mass in bOGT/;CaAkt(Tg)
was significantly improved compared to bOGT/ mice
(Figure 6G). However, the increase in b cell mass in
bOGT/;CaAkt(Tg) was normalized to control and not to the
CaAkt(Tg) level. We observed a robust increased in b cell pro-
liferation in bOGT/;CaAkt(Tg) compared to CaAkt(Tg) (Fig-
ure 6H). However, no differences in apoptosis (Figure 6I), orCell RepOGlcNAc levels were observed between islets from bOGT/
and bOGT/;CaAkt(Tg) even in the presence of enhanced
Akt signaling in bOGT/;CaAkt(Tg) as demonstrated by
increased phosphoGSK3b (Ser9) (Figure S6A and S6B). On
the other hand, we observed partial rescue of ER stress
demonstrated by enhanced proinsulin localization in the Golgi
of bOGT/;CaAkt(Tg) islets compared to proinsulin staining
in the ER of bOGT/ islets (Figure S7A). These data indicate
that Akt is sufficient to prevent diabetes in bOGT/ mice by
modulating b cell mass via proliferation and provide a mecha-
nistic link between O-GlcNAcylation and b cell survival by mod-
ulation of Akt signaling.orts 13, 2527–2538, December 22, 2015 ª2015 The Authors 2533
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Figure 6. Akt Overexpression Prevents Hyperglycemia and Improves Glucose Tolerance in Mice Lacking OGT in b Cells
(A–C) Random glucose (A), random insulin (B), and fasting insulin (C) levels in bOGT/ mice with or without Akt overexpression [CaAkt(Tg)].
(D and E) IPGTT was performed in 8- and 22-week-old bOGT/ mice with [bOGT/;CaAkt(Tg)] or without the Akt transgene [CaAkt(Tg)].
(F–I) In vivo GSIS (F), b cell mass (G), b cell proliferation (H, measured by KI67), and apoptosis (I, TUNEL) at 22-week-old bOGT/ with or without CaAkt(Tg).
*p < 0.05 and n = 4.Deletion of One Chop Allele Improves Hyperglycemia
and bCellMass inMicewithConditional Deletion of OGT
in b Cells
Chronic unfolded protein response signaling leads to the
commitment phase of ER-stress-induced apoptosis, where
C/EBP homologous protein (Chop) can trigger pro-apoptotic sig-
nals. Having demonstrated that islets from bOGT/y exhibited
increased ER stress, we tested the hypothesis that reduction
of Chop in bOGT/y ameliorates the alterations in glucose ho-
meostasis and loss of b cells. Indeed, deletion of one Chop allele
in bOGT/y (Chop+/;bOGT/y) was sufficient to lower glucose in
bOGT/y mice (Figure 7A). Six-week-old Chop+/;bOGT/y
demonstrated improved glucose tolerance compared to
Chop+/+;bOGT/y (Figure 7B). Fed insulin levels were also2534 Cell Reports 13, 2527–2538, December 22, 2015 ª2015 The Auimproved in 12-week-old Chop+/;bOGT/y compared to
Chop+/+;bOGT/y mice (Figure 7C); however, this level of insulin
was not sufficient to normalize random blood glucose level. b cell
mass was preserved in Chop+/;bOGT/y compared to
Chop+/+;bOGT/y (Figure 7D), in part, by reduction of b cell
apoptosis (Figure 7E). These data suggest that ER stress plays
a major role in the b cell failure in mice lacking OGT in b cells
and provide a direct link between O-GlcNAcylation and b cell
survival by regulation of ER stress responses.
DISCUSSION
In the present study, we define the role of O-GlcNAcylation in b
cells using several genetically modified mice. We reveal thatthors
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Figure 7. Deletion of One Allele of Chop Im-
proves Hyperglycemia and b Cell Mass in
Mice Lacking OGT in b Cells
(A) Random blood glucose levels taken at time
points indicated.
(B) IPGTT was performed in 6-week-old bOGT/y
mice expressing (Chop+/;bOGT/y) or without
one allele of Chop (Chop+/;bOGTx/y) or wild-type
control (Chop+/+;bOGTx/y).
(C) Blood insulin levels taken on 12-week-old mice
with the shown genotypes.
(D and E) b cell mass (D) and b cell apoptosis (E,
measured by TUNEL) at 12-week-old bOGT/y
with or without one allele of Chop. *p < 0.05 and
n = 4.OGT is indispensable for controlling both insulin secretion and b
cell number. Independent of mass, OGT inherently regulates in-
sulin secretion, partly due to alterations in calcium signaling and
insulin content. In addition, we identified roles of OGT in prolifer-
ation and survival specifically through modulating Akt signaling
and ER stress responses respectively. Reconstituting Akt
signaling or deletion of one Chop allele to improve ER stress
was sufficient to reduce hyperglycemia and glucose intolerance
in bOGT/ or bOGT/y (bOGT-KO)mice. These findings suggest
that impairment of O-GlcNAcylation leads to ER stress early in
life and, subsequently, deterioration of both b cell mass and
function. Together, these studies provide strong evidence of
the mechanistic link between O-GlcNAcylation, ER stress, and
Akt signaling in regulation of pancreatic b cell mass and function.
These studies identified the role of OGT at different stages of b
cell development. OGT is dispensable for b cell development
and the first 30 days of life as observed by normoglycemic and
normal b cell mass. However, young mice exhibited a defect in
insulin secretion and changes in Ca2+ signaling affecting the per-
centage of islets that oscillates and their profiles (amplitude,
period, and plateau fraction) in response to glucose, which can
all have a major impact on insulin granule release. The mecha-
nism-mediating abnormalities in intracellular Ca2+ signaling are
unclear, but it is possible that O-GlcNAcylation of proteins
involved in Ca2+ handling in b cells such as VDAC, IP3 receptor,
and SERCA could be involved as reported in cardiac tissue
(Johnsen et al., 2013; Rengifo et al., 2007). Independent of cal-
cium-mediated insulin secretion defect, young and normoglyce-
micmice lacking OGT presented lower insulin content, in part, by
reduced Ins1, Ins2, NeuroD1, and Pdx-1 mRNA messages. In
addition, Pdx-1 O-GlcNAcylation is important for binding to the
insulin gene and insulin secretion in MIN6 cells (Gao et al.,
2003). The abnormalities in insulin mRNA and content are similar
to those observed in transgenic mice with b cell-specific overex-
pression of OGA (Soesanto et al., 2011). Conversely, the currentCell Reports 13, 2527–2538, Deevidence support the notion that
enhanced O-GlcNAcylation potentiates
insulin secretion (Tang et al., 2000; Zraika
et al., 2002). Taken together, previous ev-
idence suggested that O-GlcNAcylation
regulates insulin content and secretion,
and our data identify an important rolefor O-GlcNAcylation on intracellular Ca2+ homeostasis. Further-
more, OGT could independently regulate cytoskeletal re-
organization and proteins (i.e., synapsin I, Synaptotagmin)
involved in insulin exocytosis (Cole and Hart, 1999; Fukuda,
2002).
While youngmice lacking OGT in b cells exhibited normal b cell
mass, adult mice demonstrated significant reduction in b cell
mass because of enhanced cell death and impaired proliferation.
These phenotypes were partly explained by downregulation of
prosurvival Akt and Pdx-1 signaling. Akt signaling is important
for b cell mass affecting both proliferation and apoptosis rates
(Bernal-Mizrachi et al., 2001). Islets from bOGT-KOmice demon-
strated reduced Akt phosphorylation at Ser473 compared to
control. The mechanisms underlying this effect are not clear,
but specific O-GlcNAcylation sites on Akt modulate Ser473
phosphorylation (Heath et al., 2014). Our data suggest that the
interplay between OGT and Akt signaling is prosurvival in b cells.
Overexpression of Akt in bOGT-KO mice improved glucose
tolerance and prevented the onset of frank diabetes by restoring
b cell mass in bOGT-KO mice suggesting that abnormalities in
Akt signaling could be a major mechanism for the defects
in b cell mass. Interestingly, restoration of b cell mass in
bOGT/;CaAkt(Tg) occurs mainly via proliferation and not sur-
vival. A potential role for Akt on rescuing apoptosis in bOGT-defi-
cient cells cannot be ruled out as previous data have shown that
Akt overexpressing mice exhibit a high b cell turnover with
enhanced apoptosis and proliferation (Bernal-Mizrachi et al.,
2001). It is still possible that lower levels of Akt activation could
improve survival in bOGT-deficient cells and that can be tested
in in vitro experiments. Finally, the cross talk between Akt and
OGT signaling appearsmore complex as shown by the reduction
of b cell mass in bOGT/;CaAkt(Tg) compared to OGTx/x;
CaAkt(Tg). These results suggest that reduction of OGT signaling
could modulate biological processes regulating proliferation
downstream of Akt signaling.cember 22, 2015 ª2015 The Authors 2535
Unlike adult mice lacking OGT since embryonic day 13.5,
ablating OGT in mature b cells does not cause diabetes but,
instead, glucose intolerance due to insulin secretion defect and
not mass. Thus, OGT could play a protective role in states of
chronic hyperglycemia and glucotoxicity and thereby regulating
b cell mass and function. OGT modulates O-GlcNAcylation of
proteins according to glucose level availability. Hyperglycemia
increases glucose flux through HBP, as such enhancing OGT
activity and O-GlcNAcylation. Non-physiological levels of
glucosamine promote b cell dysfunction upon chronic exposure
to hyperglycemia (Kaneto et al., 2001). In the present study, mice
lacking OGT appear to be more sensitive to glucotoxic condition
because PHZ treatment delayed the onset of diabetes and
normalized proliferation and apoptosis rate in bOGT/y mice to
that of control levels. The mechanism for the beneficial effect
of PHZ is unclear, but reduction in ER stress load may contribute
to this process. In hyperglycemic states, OGT could also lessen
glucose toxicity by increasing O-GlcNAcylation output, thereby
reducing the amount of glucosamine andO-GlcNAc in themilieu.
OGT can independently modulate proteins (i.e., CamKIV, Pdx-1,
and MafA) that regulate b cell failure in glucotoxic conditions
(Copeland et al., 2008; Gao et al., 2003; Song et al., 2008b;
Sugiyama et al., 2011; Vanderford et al., 2007). Under low
glucose levels, MafA and Pdx-1 are localized in the cytoplasm
and are transported to the nucleus after high-glucose-induced
O-GlcNAcylation. Glucotoxic conditions greatly diminish protein
levels of MafA and Pdx-1 (Robertson, 2004). Although the mech-
anisms are elusive, the process is thought to first involve the
exclusion of these proteins from the nucleus and then their
disappearance from the cytoplasm. Therefore, it is possible
that OGT deficiency in b cells during glucotoxic conditions po-
tentiates the exclusion of these proteins from the nucleus.
Our findings identified a role of O-GlcNAcylation by OGT in
ER stress responses in b cell. As mice lacking OGT age, signif-
icant b cell mass loss ensues due to ER-stress-induced
apoptosis. Although young and normoglycemic mice initially
demonstrated normal b cell mass, ER stress markers are
increased in islets of bOGT-KO mice. Interestingly, reducing
ER stress by deleting one allele of Chop was sufficient to reduce
hyperglycemia, improve glucose tolerance, and restore b cell
mass in Chop+/;bOGT/y compared to Chop+/+;bOGT/y
mice. Although insulin level was comparable between
Chop+/;bOGT/y mice and controls (Chop+/;OGTx/y or
Chop+/+;OGTx/y), it was not sufficient to normalize random
blood glucose level, and it is possible that complete deletion
of Chop could result in a complete rescue of b cell function
(Song et al., 2008a). It is of high interest in the future to identify
which protein(s) involved in the unfolded protein response are
regulated by OGT. Remarkably, Jang et al. just reported that
eukaryotic translation initiation factor 2a (eIF2a), a major branch
of the UPR, is O-GlcNAcylated at Ser219, Thr239, and Thr241,
which leads to reduced phosphorylation of eIF2a at Ser51 and
ER-stress-induced Chop activation in liver tissue (Jang et al.,
2015). Thus, OGT could regulate ER stress by modulating func-
tion of genes involved in UPR as shown in Hek293 cells, COS-7,
and neonatal rat ventricular myocytes (Ferrer et al., 2014; Jang
et al., 2015) as well as ER homeostasis by regulating proteins
involved in calcium handling as demonstrated in the heart tissue2536 Cell Reports 13, 2527–2538, December 22, 2015 ª2015 The Au(Johnsen et al., 2013; Rengifo et al., 2007). Although the exact
mechanisms contributing to ER stress in bOGT-KO mice are
not fully mapped out, it is possible that loss of OGT in b cells
alters ER homeostasis by directly affecting calcium channels
or in conjunction with alteration in UPR proteins responses.
The prosurvival effects of OGT on ER stress responses
observed in bOGT-KO mice support earlier studies by other
groups. Using C. elegans model, Denzel et al. showed that
HBP metabolites enhance protein quality control (Denzel
et al., 2014). In the heart and breast cancer cell lines, OGT
signaling has been shown to prevent ER stress (Ngoh et al.,
2009; Ferrer et al., 2014). Together, the present study supports
these findings and extends the setting in vivo and provides a
mechanism in glucose-sensitive and ER-stress-prone b cells.
In summary, our data propose OGT as a prosurvival nutrient
sensor, modulating proximal insulin signaling and targeting
specific downstream pathways to elicit diverse physiological
responses and fine-tuning mechanisms governing b cell mass
and function. As a highly expressed nutrient sensor in b cells,
OGT is poised to regulate cell proliferation, survival, and func-
tion. The coordinated actions of OGT, the enzyme that rivals
hundreds of kinases involved in phosphorylation protein modi-
fication, at multi-levels to regulate intracellular signaling
pathways in response to nutrient changes in b cells are just
beginning to unravel, and significant advances in our under-
standing of OGT action underscore the contribution of
O-GlcNAcylation in ER stress, Akt signaling, and the etiology
of type 2 diabetes.
EXPERIMENTAL PROCEDURES
Generation of O-linked GlcNAc Transferase Knockout Mice
To generate mice with conditional OGT deletion in b cells (herein referred to as
male bOGT/y [RIPCre-OGTflox/y] or female bOGT/ [RIPCre-OGTflox/flox]), we
crossed the following breeders: female OGTflox/flox and male mice harboring
one allele of Cre-recombinase under the rat insulin 2 promoter (RIPCre) (Fig-
ure S1C, RIPCre, provided by Dr. Pedro Herrera, University of Geneva Faculty
of Medicine, Geneva, Switzerland) or the inducible mouse insulin promoter
(MIPCre-ERTM, Dr. Louis H. Philipson, University of Chicago). Homozygous
female bOGT/ was generated by breeding female OGTflox/flox and male
RIPCre-OGTflox/y. Littermate offspring with or without the RIP or MIPCre trans-
gene were analyzed. Schematic diagram of breeding is shown in Figure S1A.
C57BL/6, OGTflox/flox, and Chop/+ animals were purchased from Jackson
Laboratory. The generation of Akt transgenic mice [caAkt(Tg)] was previously
described (Bernal-Mizrachi et al., 2001). All procedures were performed in
accordance with the University of Michigan Animal Studies Committee.
Islet Isolation
Primary mouse islets from young and normoglycemic male bOGT/y or female
bOGT/ mice were isolated using collagenase (1 mg/ml, Roche Applied
Science) and hand picked after filtration with a 70-mm cell strainer (BD Falcon)
as described previously (Alejandro et al., 2014).
Western Blotting
Immunoblotting was performed as described previously (Alejandro et al.,
2014). Briefly, islet cells were washed after treatments with PBS before adding
cell lysis buffer (Cell Signaling Technology) with protease inhibitor cocktail and
phoshopStop tablets (Roche Applied Science). Primary antibodies against
OGT, O-GlcNAc, and Vinculin were from Abcam. Pdx-1 antibody was pur-
chased from Millipore. Phosphorylated S6 (Ser240), GSK3b (Ser9), and Akt
(Ser473, Thr308) and total Akt antibodies were from Cell Signaling. Antibodies
against b-actin and tubulin were from Sigma and Chop was from Santa Cruzthors
Biotechnology. Caspase-12 was from Bioscience. Pro-insulin antibody is from
ALPCO. Bip antibody was generated by P.A.’s laboratory.
b Cell Mass, Proliferation, and TUNEL Analysis
Formalin-fixed pancreas tissues were embedded into paraffin. Sections
were deparaffinized, rehydrated, and incubated with blocking solution as
previously described (Bernal-Mizrachi et al., 2001). Sections were
incubated overnight at 4C with antibodies against insulin (Dako), OGT
(Abcam), followed by secondary antibodies conjugated to FITC and Cy3
(Jackson ImmunoResearch). DAPI-containing mounting media (Vector Lab-
oratories) was added to coverslips. b cell mass analysis entails assessing
total pancreas and insulin-positive cell areas from five insulin-stained
sections (5 mm) separated 200 mm were measured by using Image Pro Soft-
ware (Media Cybernetics). b cell mass (average b cell fraction multiplied by
pancreas weight) assessment was performed using Surveyor Software
(Objective Imaging) automated scanning with a Leica fluorescent micro-
scope (Leica Microsystems). Cell proliferation and apoptosis were analyzed
using co-staining of Ki67 or TUNEL with insulin on tissue sections of control
and knockout mice. At least 3,000 stained cells were counted from each
animal.
Mouse Pancreas Confocal Imaging and Proinsulin Analysis
Pancreata from 4-week-old male bOGT/y and control were prepared as
mentioned above but deparaffinized and stained as previously described
(Haataja et al., 2013; Wright et al., 2013). For quantification of wild-type proin-
sulin localization, sections were immunostained with anti-proinsulin (ALPCO),
anti-calnexin, and anti-insulin antibodies, and a blinded reader scored the
localization of proinsulin in b cells as either a predominant juxtanuclear cres-
cent of increased intensity (Golgi) or mainly diffused and colocalized with cal-
nexin (ER) (Wright et al., 2013). An average of 715 insulin-positive b cells
(approximately six islets) was analyzed per genotype.
Glucose and Insulin Tolerance Tests
Fasting glucose levels were measured after an overnight fasting. Glucose
tolerance tests were performed by intraperitoneal delivery of 2 g/kg glucose
to mice after 12 hr of fasting. Insulin tolerance test was done with 0.75Unit/kg
insulin (Humalog, Eli Lilly) to mice after 6-hr fasting. Blood glucose was moni-
tored for 2 hr after glucose or insulin injection. Plasma insulin levels were
measured using ultra-sensitive mouse insulin ELISA kit (ALPCO).
Measurement of Intracellular Ca2+
Isolated islets were allowed to recover overnight from islet isolation prior to
measurement of intracellular Ca2+. Islets were preloaded with 2.5 mM Fura2-
AM (Molecular Probes) in 0.1% DMSO for 30 min at 37C and washed for
10 min before recording. The recording solution contained, in mM 145 NaCl,
5 KCl, 1.2 MgCl2, 2.6 CaCl2, 10 HEPES, and glucose as indicated (pH 7.4).
Ca2+ is reported as the ratio of alternative excitation at 340 nm/380 nm, with
emission measured at 510 nm (Merrins et al., 2013).
Phloridzin Transplantation Studies
Weutilized ALZETOsmotic Pumps (Model 2006, pump flow rate = 0.15ul/hr) to
continuously deliver a dose of 0.8 mg/kg/day (5 mg/ml) of Phloridzin (Sigma)
for 25 days in two cohorts of bOGT/ and littermates control: cohort 1 was
70-day-old mice with an average body weight of 25.0 g. Cohort 2 was 50-
day-old with an average weight of 20.5 g. Mice were anesthetized with intra-
peritoneal injection of ketamine (100 mg/kg body weight) and xylazine
(10 mg/kg body weight), and ALZET pumps were implanted subcutaneously
to all mice. Mice were fully recuperated from the surgery before the in vivo ex-
periments were performed.
Transmission Electron Microscopy
Philips CM-100 electronmicroscope at 60 kVwas utilized to examine ultra-thin
sections (70 nm) of isolated islets fixed with 2.5% glutaraldehyde in 0.1 M
Sorensen buffer, post-fixed in OsO4, and stained with 3%uranyl acetate. Meg-
aplus camera system was operated using AMT software (Advanced Micro-
scopy Techniques).Cell RepStatistical Analysis
Data are presented asmean ±SEM. Data were analyzed using non-parametric
Mann-Whitney tests (U test) using GraphPad Prism v.6 (GraphPad). Results
were considered statistically significant when the p value was <0.05.
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